Clinical outcomes from skin screening clinics within a community-based melanoma screening program

Aitken, Joanne F.; Janda, Monika; Elwood, Mark; Youl, Philippa; Ring, Ian; Lowe, John B.

doi:10.1016/j.jaad.2005.08.072

Cited by 97 publications

(94 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Evaluation of the SCREEN project revealed that 620 persons had to be screened to find one histopathologically confirmed MM (1.6 MM per 1,000 persons [24]). This number is in line with numbers from screening programs of the Australian and American Academy of Dermatologists [25,26], but it is lower than findings from European screening programs, such as the Euromelanoma Week, which target high-risk groups [27,28] in contrast to the mass screening in the SCREEN project. During SCREEN, a total of 15,983 excisions were performed, and the number needed to excise (NNE) to detect one histopathologically confirmed MM in men and women was 28.…”

Section: Steps Towards a Standardized And Systematic Skin Cancer Scresupporting

confidence: 74%

Benefits and Risks of Skin Cancer Screening

Breitbart¹,

Choudhury²,

Anders³

et al. 2014

Oncol Res Treat

View full text Add to dashboard Cite

Section: Steps Towards a Standardized And Systematic Skin Cancer Scresupporting

confidence: 74%

Benefits and Risks of Skin Cancer Screening

Breitbart¹,

Choudhury²,

Anders³

et al. 2014

Oncol Res Treat

View full text Add to dashboard Cite

“…21 These results also support the notion that the natural increase in removal of benign lesions and KCs through a screening program for melanoma may positively influence screening participation during subsequent rounds by increasing awareness of the importance of skin checks. 31 Conversely, future screening programs will need to target those men age !50 years who never had a spot or mole removed and who are unconcerned about a mole or spot to raise their attendance rates.…”

Section: Discussionmentioning

confidence: 99%

What motivates men age ≥ 50 years to participate in a screening program for melanoma?

Janda

Youl

Lowe

et al. 2006

Cancer

Self Cite

View full text Add to dashboard Cite

BACKGROUND.The screening behavior and screening outcomes of men age ≥50 years was investigated within a randomized controlled trial of a community‐based intervention of screening for melanoma, consisting of a community education program, an education program for medical practitioners, and the provision of dedicated skin‐screening clinics.METHODS.Data from cross‐sectional telephone surveys before (559 completed interviews), at the end (591 completed interview), and at 2 years after the intervention (445 completed interviews) were analyzed. In addition, the authors analyzed data from skin‐screening clinics within the intervention program (3355 men age ≥50 years participated).RESULTS.During the intervention period men age ≥50 years increased both their screening behavior and intention to screen. Those men age ≥50 years who reported a past history of removal of a mole as well as other risk factors for skin cancer and positive attitudes toward screening were more likely to participate in skin screening across time. Men age ≥50 years accounted for 20.5% of all skin‐screening clinic attendees, 31.3% of those referred for a suspicious lesion, 48.5% of melanomas, and 45% of all keratinocyte carcinomas diagnosed within the screening program, respectively.CONCLUSIONS.The intervention program successfully motivated men age ≥50 years to attend screening for skin cancer, resulting in the highest yield of skin cancer within this subgroup of the population. Messages addressing skin cancer risk factors and attitudes toward skin cancer and screening could be used to target a screening program for melanoma toward men age ≥50 years. Cancer 2006. © 2006 American Cancer Society.

show abstract

“…122 It is possible that placing additional responsibilities on a primary care visit may actually interfere with secondary detection of conditions such as skin cancers or depression. [123][124][125] Finally, there are limitations in the methods used in this review. The quality of each study was subjectively determined and could not be analyzed in the aggregate because most studies and evaluations used different interventions and approaches to data collection.…”

Section: Limitations Of This Reviewmentioning

confidence: 99%

The Medical Home: Growing Evidence to Support a New Approach to Primary Care

Rosenthal¹

2008

The Journal of the American Board of Family Medicine

446

341

View full text Add to dashboard Cite

Introduction:A medical home is a patient-centered, multifaceted source of personal primary health care. It is based on a relationship between the patient and physician, formed to improve the patient's health across a continuum of referrals and services. Primary care organizations, including the American Board of Family Medicine, have promoted the concept as an answer to government agencies seeking political solutions that make quality health care affordable and accessible to all Americans.Methods: Standard literature databases, including PubMed, and Internet sites of numerous professional associations, government agencies, business groups, and private health organizations identified over 200 references, reports, and books evaluating the medical home and patient-centered primary care.Findings: Evaluations of several patient-centered medical home models corroborate earlier findings of improved outcomes and satisfaction. The peer-reviewed literature documents improved quality, reduced errors, and increased satisfaction when patients identify with a primary care medical home. Patient autonomy and choice also contributes to satisfaction. Although industry has funded case management models demonstrating value superior to traditional fee-for-service reimbursement adoption of the medical home as a basis for medical care in the United States, delivery will require effort on the part of providers and incentives to support activities outside of the traditional face-to-face office visit.Conclusions: Evidence from multiple settings and several countries supports the ability of medical homes to advance societal health. A combination of fee-for-service, case management fees, and quality outcome incentives effectively drive higher standards in patient experience and outcomes. Community/ provider boards may be required to safeguard the public interest.

show abstract

Clinical outcomes from skin screening clinics within a community-based melanoma screening program

Cited by 97 publications

References 25 publications

Benefits and Risks of Skin Cancer Screening

Benefits and Risks of Skin Cancer Screening

What motivates men age ≥ 50 years to participate in a screening program for melanoma?

The Medical Home: Growing Evidence to Support a New Approach to Primary Care

Contact Info

Product

Resources

About